Frontiers in public health · 2026
Assessing the prevalence of anosmia and taste dysfunction in COVID-19 patients in Saudi Arabia: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aldrees Turki
Аннотация
OBJECTIVES: Patients with coronavirus disease-2019 (COVID-19) frequently report olfactory and gustatory dysfunctions, including anosmia and ageusia. Multiple studies have assessed the prevalence of these symptoms in COVID-19 patients in Saudi Arabia. This systematic review and meta-analysis aimed to estimate the pooled prevalence of anosmia and taste dysfunction in confirmed COVID-19 patients in Saudi Arabia across inpatient, outpatient, and community settings, from March 2020 to March 2023.
METHODS: A systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines. No review protocol was prospectively registered prior to this review. A comprehensive search was conducted across PubMed, ScienceDirect, CINAHL, MEDLINE, and Google Scholar (supplementary) from 1 March 2020 to 1 March 2023. Data were pooled using a random-effects model. The methodological quality of included studies was evaluated using the Joanna Briggs Institute (JBI) critical appraisal tools for prevalence studies.
RESULTS: Of 230 records identified across all databases, 156 remained after deduplication; 24 met the eligibility criteria, encompassing 26,068 COVID-19 patients (58.2% female). The pooled prevalence of anosmia was 44% (95% CI: 37-52%) and of taste dysfunction was 46% (95% CI: 39-54%). Subgroup analyses comparing validated versus non-validated assessment instruments revealed no statistically significant difference in prevalence estimates.
CONCLUSION: Anosmia and taste loss are common manifestations of COVID-19 in Saudi Arabia. The findings should be interpreted with caution given the methodological heterogeneity of included studies, reliance on self-reported measures in the majority of studies, and the absence of a prospectively registered protocol. Future studies using objective validated instruments are warranted.
METHODS: A systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines. No review protocol was prospectively registered prior to this review. A comprehensive search was conducted across PubMed, ScienceDirect, CINAHL, MEDLINE, and Google Scholar (supplementary) from 1 March 2020 to 1 March 2023. Data were pooled using a random-effects model. The methodological quality of included studies was evaluated using the Joanna Briggs Institute (JBI) critical appraisal tools for prevalence studies.
RESULTS: Of 230 records identified across all databases, 156 remained after deduplication; 24 met the eligibility criteria, encompassing 26,068 COVID-19 patients (58.2% female). The pooled prevalence of anosmia was 44% (95% CI: 37-52%) and of taste dysfunction was 46% (95% CI: 39-54%). Subgroup analyses comparing validated versus non-validated assessment instruments revealed no statistically significant difference in prevalence estimates.
CONCLUSION: Anosmia and taste loss are common manifestations of COVID-19 in Saudi Arabia. The findings should be interpreted with caution given the methodological heterogeneity of included studies, reliance on self-reported measures in the majority of studies, and the absence of a prospectively registered protocol. Future studies using objective validated instruments are warranted.